SERUM PROTEIN ENHANCEMENT OF ANTIBIOTIC THERAPY IN CRYPTOCOCCOSIS

被引:31
作者
GORDON, MA
LAPA, E
机构
关键词
D O I
10.1093/infdis/114.4.373
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:373 / +
页数:1
相关论文
共 18 条
[1]  
ALLEN WP, 1955, DISSERTATION U MICHI
[2]  
ANDERSEN KEVIN, 1958, MED JOUR AUSTRALIA II, V45, P601
[3]   CHARACTERIZATION OF GROWTH INHIBITION FACTOR FOR CRYPTOCOCCUS NEOFORMANS (GIFC) IN HUMAN SERUM [J].
BAUM, GL ;
ARTIS, D .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1963, 246 (01) :53-&
[4]  
BLOOMFIELD N, 1963, P SOC EXP BIOL MED, V114, P64, DOI 10.3181/00379727-114-28586
[5]  
EMMONS CW, 1961, AM REV RESPIR DIS, V84, P507
[6]  
GADEBUSCH HH, 1958, P SOC EXP BIOL MED, V98, P611, DOI 10.3181/00379727-98-24123
[7]  
GERKE JR, 1961, ANTIBIOT CHEMOTHER, V11, P227
[8]  
GORDON MA, 1962, SABOURAUDIA, V2, P23
[9]   SOME FACTORS WHICH AFFECT INITIATION OF GROWTH OF CRYPTOCOCCUS NEOFORMANS [J].
HOWARD, DH .
JOURNAL OF BACTERIOLOGY, 1961, 82 (03) :430-&
[10]   CRYPTOCOCCOSIS (TORULOSIS) - CURRENT CONCEPTS AND THERAPY [J].
LITTMAN, ML .
AMERICAN JOURNAL OF MEDICINE, 1959, 27 (06) :976-998